Is Type 2 Diabetes Mellitus a Cause of Severe Erectile Dysfunction in Patients With Metabolic Syndrome?

Urology

Volumn 74, Issue 3, 2009, Pages 561-564

  Aslan, Yilmaz ^a   Sezgin, Tezcan ^a   Tuncel, Altug ^a   Tekdogan, Umit Y ^a   Guler, Serdar ^b   Atan, Ali ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Ankara Numune Educational and Training Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE SEVERITY; ERECTILE DYSFUNCTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PARAMETER; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SCORING SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; ERECTILE DYSFUNCTION; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 69249222610     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.02.073     Document Type: Article

References (25)

1. Grundy S.M., Cleeman J.I., Daniels S.R., et al., American Heart Association and National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005) 2735-2752
2. Demir T., Demir O., Kefi A., et al. Prevalence of erectile dysfunction in patients with metabolic syndrome. Int J Urol 13 (2006) 385-388
3. Heidler S., Temml C., Broessner C., et al. Is the metabolic syndrome an independent risk factor for erectile dysfunction?. J Urol 177 (2007) 651-654
4. Bal K., Oder M., Sahin A.S., et al. Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction. Urology 69 (2007) 356-360
5. Gunduz M.I., Gumus B.H., and Sekuri C. Relationship between metabolic syndrome and erectile dysfunction. Asian J Androl 6 (2004) 355-358
6. Vlachopoulos C., Rokkas K., Ioakeimidis N., et al. Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. Eur Urol 52 (2007) 1590-1600
7. Meigs J.B., Wilson P.W., Nathan D.M., et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio heart and Framingham offspring studies. Diabetes 52 (2003) 2160-2167
8. Hanley A.J., Festa A., D'Agostino Jr. R.B., et al. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes 53 (2004) 1773-1781
9. Goldstraw M.A., Kirby M.G., Bhardwa J., et al. Diabetes and the urologist: a growing problem. BJU Int 99 (2007) 513-517
10. Melman A., and Gingell J.C. The epidemiology and pathophysiology of erectile dysfunction. J Urol 161 (1999) 5-11
11. Rosen R.C., Cappelleri J.C., Smith M.D., et al. Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11 (1999) 319-326
12. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org
13. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
14. De Berardis G., Pellegrini F., Franciosi M., et al., QuED (quality of care and outcomes in type 2 diabetes) Study Group. Longitudinal assessment of quality of life in patients with type 2 diabetes and self-reported erectile dysfunction. Diab Care 28 (2005) 2637-2643
15. Feldman H.A., Goldstein I., Hatzichristou D.G., et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 151 (1994) 54-61
16. Rendell M.S., Rajfer J., Wicker P.A., et al., Sildenafil Diabetes Study Group. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. JAMA 281 (1999) 421-426
17. Palumbo P.J. Metabolic risk factors, endothelial dysfunction, and erectile dysfunction in men with diabetes. Am J Med Sci 334 (2007) 466-480
18. McCulloch D.K., Young R.J., Prescott R.J., et al. The natural history of impotence in diabetic men. Diabetologia 26 (1984) 437-440
19. Rhoden E.L., Ribeiro E.P., Riedner C.E., et al. Glycosylated haemoglobin levels and the severity of erectile function in diabetic men. BJU Int 95 (2005) 615-617
20. Al-Hunayan A., Al-Mutar M., Kehinde E.O., et al. The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus. BJU Int 99 (2007) 130-134
21. American Diabetes Association. Standards of medical care in diabetes. Diab Care 38 (2005) 4-36
22. Fowler M.J. Microvascular and macrovascular complications of diabetes. Clin Diab 26 (2008) 77-82
23. Laaksonen D.E., Niskanen L., Punnonen K., et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diab Care 27 (2004) 1036-1041
24. Yeh H.C., Wang C.J., Lee Y.C., et al. Association among metabolic syndrome, testosterone level and severity of erectile dysfunction. Kaohsiung J Med Sci 24 (2008) 240-247
25. Farrell J.B., Deshmukh A., and Baghaie A.A. Low testosterone and the association with type 2 diabetes. Diab Educ 34 (2008) 799-806